Acer Therapeutics Inc. (ACER) Social Stream
ACER THERAPEUTICS INC (ACER) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACER.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ACER's average price target has moved down $5.75 over the prior 26 months.
ACER reports an average of 919.28% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACER Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, ACER's average broker recommendation rating worsened by 1.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ACER THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 480.28% of that group.
- To contextualize these metrics, consider that out of all US stocks, ACER THERAPEUTICS INC's number of analysts covering the stock is greater than 21.98% of them.
- ACER has a greater average analyst price target than 46.94% of all US stocks.
- In the context of Pharmaceutical Products stocks, ACER THERAPEUTICS INC's variance in analysts' estimates is lower than -27.23% of them.
What is the outlook for ACER? Use POWR Ratings for clearer insight into price direction.